PH18135A - N-thiazolylmethylthioalkyl-n'-alkylamidines,compositions and method of inhibiting gastric acid secretion - Google Patents
N-thiazolylmethylthioalkyl-n'-alkylamidines,compositions and method of inhibiting gastric acid secretionInfo
- Publication number
- PH18135A PH18135A PH26296A PH26296A PH18135A PH 18135 A PH18135 A PH 18135A PH 26296 A PH26296 A PH 26296A PH 26296 A PH26296 A PH 26296A PH 18135 A PH18135 A PH 18135A
- Authority
- PH
- Philippines
- Prior art keywords
- thiazolylmethylthioalkyl
- alkylamidines
- compositions
- gastric acid
- acid secretion
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/28—Radicals substituted by nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/193,192 US4375547A (en) | 1980-10-02 | 1980-10-02 | N-Methyl-N'-2-([(2-dimethylaminomethyl)-4-thiazolyl]methylthio)ethyl 2-nitro-1,1-ethenediamine |
Publications (1)
Publication Number | Publication Date |
---|---|
PH18135A true PH18135A (en) | 1985-04-03 |
Family
ID=22712591
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PH26296A PH18135A (en) | 1980-10-02 | 1981-10-01 | N-thiazolylmethylthioalkyl-n'-alkylamidines,compositions and method of inhibiting gastric acid secretion |
Country Status (36)
Country | Link |
---|---|
US (1) | US4375547A (da) |
EP (1) | EP0049618B1 (da) |
JP (1) | JPS5791980A (da) |
KR (1) | KR850001795B1 (da) |
AR (1) | AR241439A1 (da) |
AU (1) | AU542553B2 (da) |
BG (1) | BG60249B2 (da) |
CA (1) | CA1166248A (da) |
CS (1) | CS227015B2 (da) |
CY (1) | CY1351A (da) |
DD (1) | DD200371A5 (da) |
DE (1) | DE3171819D1 (da) |
DK (2) | DK164056C (da) |
EG (1) | EG15678A (da) |
ES (2) | ES8301950A1 (da) |
FI (2) | FI76570C (da) |
GB (1) | GB2084581B (da) |
GR (1) | GR75023B (da) |
HK (1) | HK15987A (da) |
HU (1) | HU188697B (da) |
IE (1) | IE51603B1 (da) |
IL (1) | IL63980A (da) |
LU (1) | LU88293I2 (da) |
MX (1) | MX5723A (da) |
MY (1) | MY8700247A (da) |
NL (1) | NL930107I2 (da) |
NO (1) | NO155885C (da) |
NZ (1) | NZ198523A (da) |
PH (1) | PH18135A (da) |
PL (2) | PL130526B1 (da) |
PT (1) | PT73757B (da) |
RO (2) | RO85815B (da) |
SU (1) | SU1184443A3 (da) |
UA (1) | UA6081A1 (da) |
YU (1) | YU42728B (da) |
ZA (1) | ZA816817B (da) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4904792A (en) * | 1980-10-02 | 1990-02-27 | Eli Lilly And Company | N-thiazolymethylthioalkyl-N'-alkylamidines and related compounds |
NZ202797A (en) * | 1981-12-28 | 1985-08-30 | Lilly Co Eli | Pyrimidine derivatives and pharmaceutical compositions |
US4474794A (en) * | 1982-03-19 | 1984-10-02 | Eli Lilly And Company | N-Thiazolylmethylthioalkyl-N1 -alkenyl (or alkynyl)guanidines and related compounds |
FR2531703A1 (fr) * | 1982-08-13 | 1984-02-17 | Sanofi Sa | 2-aza-5-thiahexan-1-ones 1,6-disubstituees, leurs sels, procede pour leur preparation et compositions pharmaceutiques les renfermant |
US4587344A (en) * | 1983-02-07 | 1986-05-06 | Eli Lilly And Company | Isothiourea synthesis process |
ES8601941A1 (es) * | 1983-02-07 | 1985-11-01 | Lilly Co Eli | Un procedimiento para la preparacion de nizatidina |
US4468517A (en) * | 1983-05-12 | 1984-08-28 | Eli Lilly And Company | Synthesis of thiazoles |
DE3417127A1 (de) * | 1984-05-09 | 1985-11-14 | Papst-Motoren GmbH & Co KG, 7742 St Georgen | Kleinstventilator |
DE3531504A1 (de) * | 1985-09-04 | 1987-03-12 | Basf Ag | 3-aminomethylpyrrol-1-yl-alkylamine und diese verbindungen enthaltende therapeutische mittel |
IL80961A0 (en) * | 1985-12-18 | 1987-03-31 | Lilly Co Eli | Synthesis of nizatidine |
US4777260A (en) * | 1985-12-18 | 1988-10-11 | Eli Lilly And Company | Synthesis of nizatidine intermediate |
ES2053462T3 (es) * | 1987-04-06 | 1994-08-01 | Heumann Pharma Gmbh & Co | Procedimiento para la produccion de derivados de nitroetano. |
ES2007959A6 (es) * | 1988-07-11 | 1989-07-01 | Vinas Lab | Procedimiento para la obtencion de derivados tiazolicos. |
PT515121E (pt) * | 1991-05-21 | 2001-04-30 | Lilly Co Eli | Processo para preparar intermediarios da nizatidina e compostos relacionados |
ES2038922B1 (es) * | 1991-12-30 | 1994-04-16 | Fermentaciones Y Sintesis Espa | Procedimiento para la obtencion de nizatidina. |
US5294433A (en) * | 1992-04-15 | 1994-03-15 | The Procter & Gamble Company | Use of H-2 antagonists for treatment of gingivitis |
AU662454B2 (en) * | 1992-05-12 | 1995-08-31 | Zeria Pharmaceutical Co., Ltd. | Novel quaternary ammonium salts and use thereof as medicine |
US5541335A (en) * | 1994-07-11 | 1996-07-30 | Torcan Chemical Ltd. | Process for preparing nizatidine |
US5470865A (en) * | 1994-08-30 | 1995-11-28 | Eli Lilly And Company | Pharmaceutical composition |
EP0927172A1 (en) * | 1996-09-11 | 1999-07-07 | Knoll Aktiengesellschaft | Process for the preparation of nizatidine |
IT1299198B1 (it) * | 1998-03-05 | 2000-02-29 | Nicox Sa | Sali nitrati di farmaci antiulcera |
WO2000028988A1 (en) | 1998-11-17 | 2000-05-25 | Nitromed, Inc. | Nitrosated and nitrosylated h2 receptor antagonist compounds, compositions and methods of use |
EP1579862A1 (en) | 2004-03-25 | 2005-09-28 | Boehringer Ingelheim Vetmedica Gmbh | Use of PDE III inhibitors for the reduction of heart size in mammals suffering from heart failure |
US8980894B2 (en) | 2004-03-25 | 2015-03-17 | Boehringer Ingelheim Vetmedica Gmbh | Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure |
US20080044481A1 (en) * | 2004-05-27 | 2008-02-21 | Mordechai Harel | Microparticles for Oral Delivery |
WO2006071659A1 (en) * | 2004-12-29 | 2006-07-06 | Trustees Of Boston University | Delivery of h2 antagonists |
EP1920785A1 (en) | 2006-11-07 | 2008-05-14 | Boehringer Ingelheim Vetmedica Gmbh | Liquid preparation comprising a complex of pimobendan and cyclodextrin |
US20090275622A1 (en) * | 2008-04-30 | 2009-11-05 | Prasoona Linga | Nizatidine formulations |
US10398705B2 (en) | 2012-03-15 | 2019-09-03 | Boehringer Ingelheim Vetmedica Gmbh | Pharmaceutical tablet formulation for the veterinary medical sector, method of production and use thereof |
CN105377235A (zh) | 2013-07-19 | 2016-03-02 | 勃林格殷格翰动物保健有限公司 | 含有防腐的醚化的环糊精衍生物的液体水性药物组合物 |
CA3176466A1 (en) | 2013-12-04 | 2015-06-11 | Boehringer Ingelheim Vetmedica Gmbh | Improved pharmaceutical compositions of pimobendan |
EP2929884A1 (en) | 2014-04-11 | 2015-10-14 | Sanovel Ilac Sanayi ve Ticaret A.S. | Pharmaceutical combinations of dabigatran and h2-receptor antagonists |
EP2942058A1 (en) | 2014-05-09 | 2015-11-11 | Sanovel Ilac Sanayi ve Ticaret A.S. | Pharmaceutical combinations of rivaroxaban and H2-receptor antagonists |
US10537570B2 (en) | 2016-04-06 | 2020-01-21 | Boehringer Ingelheim Vetmedica Gmbh | Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease |
EP4196793A1 (en) | 2020-08-11 | 2023-06-21 | Université de Strasbourg | H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1338169A (en) * | 1971-03-09 | 1973-11-21 | Smith Kline French Lab | Ureas thioureas and guanidines |
US3917593A (en) * | 1972-05-22 | 1975-11-04 | Smithkline Corp | N-alkenyl and N-alkynyl (2-quinolyl)thio-acetamides |
US3853865A (en) * | 1972-06-26 | 1974-12-10 | Smithkline Corp | N-aminomethyl-2-amino(and 2-amino-methyl)-2-heterocyclic-thioacetamides |
GB1421792A (en) * | 1973-05-17 | 1976-01-21 | Smith Kline French Lab | Heterocyclic substituted-1, 1-diamino-ethylene derivatives methods for their preparation and compositions containing them |
US4191769A (en) * | 1974-03-12 | 1980-03-04 | Smith Kline & French Laboratories Limited | Isothiourea compounds and pharmacological use |
US4061637A (en) * | 1974-05-14 | 1977-12-06 | Istituto Luso Farmaco D'italia S.R.L. | Certain 4-aryl-5-(4-phenylpiperazino)alkyl-4-thiazolin-2-ones |
US4173644A (en) * | 1975-02-03 | 1979-11-06 | Smith Kline & French Laboratories Limited | Thiourea compounds, compositions and methods and use |
US4166856A (en) * | 1975-05-21 | 1979-09-04 | Smith Kline & French Laboratories Limited | Thiazole and isothiazole derivative as blockers of histamine H2 -receptors |
GB1574214A (en) * | 1976-03-11 | 1980-09-03 | Smith Kline French Lab | Amidines |
GB1602458A (en) * | 1977-05-05 | 1981-11-11 | Smith Kline French Lab | Bisamidines as histamine h2-antagonists |
DE2835695A1 (de) * | 1977-08-29 | 1979-03-15 | Yamanouchi Pharma Co Ltd | Neue heterocyclische verbindungen, verfahren zu ihrer herstellung und arzneimittel, die diese enthalten |
JPS5444660A (en) * | 1977-08-29 | 1979-04-09 | Yamanouchi Pharmaceut Co Ltd | Heterocyclic compound and its preparation |
US4210658A (en) * | 1977-09-08 | 1980-07-01 | Smith Kline & French Laboratories Limited | Amidinosulphonic acid derivatives |
DE2905134A1 (de) * | 1978-02-17 | 1979-08-23 | Degussa | Neue acylierte aminoalkyl-cyanoguanidine mit einem heterocyclischen rest |
DE2963363D1 (en) * | 1978-05-24 | 1982-09-09 | Ici Plc | Antisecretory thiadiazole derivatives, processes for their manufacture and pharmaceutical compositions containing them |
US4200578A (en) * | 1978-12-18 | 1980-04-29 | Bristol-Myers Company | Thiazole derivatives |
-
1980
- 1980-10-02 US US06/193,192 patent/US4375547A/en not_active Expired - Lifetime
-
1981
- 1981-10-01 YU YU2364/81A patent/YU42728B/xx unknown
- 1981-10-01 CS CS817182A patent/CS227015B2/cs unknown
- 1981-10-01 NZ NZ198523A patent/NZ198523A/en unknown
- 1981-10-01 ES ES505950A patent/ES8301950A1/es not_active Expired
- 1981-10-01 FI FI813058A patent/FI76570C/fi not_active IP Right Cessation
- 1981-10-01 IE IE2285/81A patent/IE51603B1/en not_active IP Right Cessation
- 1981-10-01 CA CA000387139A patent/CA1166248A/en not_active Expired
- 1981-10-01 ZA ZA816817A patent/ZA816817B/xx unknown
- 1981-10-01 RO RO110860A patent/RO85815B/ro unknown
- 1981-10-01 DK DK435181A patent/DK164056C/da not_active IP Right Cessation
- 1981-10-01 PH PH26296A patent/PH18135A/en unknown
- 1981-10-01 RO RO81105440A patent/RO82215A/ro unknown
- 1981-10-01 HU HU812844A patent/HU188697B/hu unknown
- 1981-10-01 UA UA3344304A patent/UA6081A1/uk unknown
- 1981-10-01 IL IL63980A patent/IL63980A/xx not_active IP Right Cessation
- 1981-10-01 AU AU75945/81A patent/AU542553B2/en not_active Expired
- 1981-10-01 PT PT73757A patent/PT73757B/pt unknown
- 1981-10-01 SU SU813344304A patent/SU1184443A3/ru active
- 1981-10-01 NO NO813334A patent/NO155885C/no not_active IP Right Cessation
- 1981-10-01 FI FI810358A patent/FI813058L/fi not_active Application Discontinuation
- 1981-10-02 GB GB8129855A patent/GB2084581B/en not_active Expired
- 1981-10-02 BG BG53730A patent/BG60249B2/xx unknown
- 1981-10-02 JP JP56158594A patent/JPS5791980A/ja active Granted
- 1981-10-02 DE DE8181304572T patent/DE3171819D1/de not_active Expired
- 1981-10-02 PL PL1981233295A patent/PL130526B1/pl unknown
- 1981-10-02 DD DD81233851A patent/DD200371A5/de unknown
- 1981-10-02 KR KR1019810003721A patent/KR850001795B1/ko active
- 1981-10-02 GR GR66193A patent/GR75023B/el unknown
- 1981-10-02 CY CY135181A patent/CY1351A/xx unknown
- 1981-10-02 PL PL1981238035A patent/PL130626B1/pl unknown
- 1981-10-02 EP EP81304572A patent/EP0049618B1/en not_active Expired
- 1981-10-03 EG EG566/81A patent/EG15678A/xx active
-
1982
- 1982-08-09 ES ES514868A patent/ES514868A0/es active Granted
- 1982-11-09 AR AR82291229A patent/AR241439A1/es active
-
1986
- 1986-11-25 MX MX572386A patent/MX5723A/es unknown
-
1987
- 1987-02-19 HK HK159/87A patent/HK15987A/xx not_active IP Right Cessation
- 1987-12-30 MY MY247/87A patent/MY8700247A/xx unknown
-
1991
- 1991-01-24 DK DK012391A patent/DK167759B1/da not_active IP Right Cessation
-
1993
- 1993-06-09 LU LU88293C patent/LU88293I2/fr unknown
- 1993-06-29 NL NL930107C patent/NL930107I2/nl unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH18135A (en) | N-thiazolylmethylthioalkyl-n'-alkylamidines,compositions and method of inhibiting gastric acid secretion | |
DE3372567D1 (en) | Stabilized solid compositions and method of making them | |
IL63839A0 (en) | N-arylbenzamides,herbicidal compositions containing them and method of using them | |
GB2113089B (en) | Inhibiting the secretion of stomach acid | |
PH18392A (en) | Novel quinolone compounds,compositions containing same and method of use thereof | |
EG15446A (en) | Method of preparation 2-amino-3-cabethoxyamino-6-(fluro-benzylamino)-pyridine-maleate | |
GB2087383B (en) | Preparation of 1,1,1,3,3,-hexafluoropropane-2-ol | |
GB2117416A (en) | Method of quenching | |
JPS5714570A (en) | Preparation of n-benzyloxycarbonylaspartic acid | |
PH17034A (en) | Novel compositions and processes | |
IL71446A0 (en) | Composition and method for the preparation of 1,8-dihydroxy-10-acyl-9-anthrones | |
JPS5726666A (en) | Manufacture of 1-amino-8-hydroxynaphthalene- sulfonic acid having substituted amino group | |
JPS57165373A (en) | Guanidine derivative, manufacture and medicinal composition containing same for gastric acid secretion inhibition | |
JPS57108059A (en) | Manufacture of 1,4-diamino-anthraquinone-2- sulfonic acid | |
GB2155926B (en) | Method of preparing trifluoroacetic acid from trichlorotrifluoroethane | |
JPS5777647A (en) | Manufacture of alpha-benzamide-alpha'- halogeno-1,1'-dianthraimide | |
JPS57171980A (en) | Guanidine derivative, manufacture and gastric acid secretion inhibitor containing same | |
SG92087G (en) | Water-soluble salts of 2,4-diamino-5-methyl-6-((3,4,5-trimethoxyanilino) methyl) quinazo-line, compositions containing such salts and the production of such salts | |
ZA822116B (en) | Therapeutical composition useful as digestive topic | |
JPS56128738A (en) | Manufacture of n,n,n',n'-tetraalkylimino-bis- alkylamine | |
PL243722A1 (en) | Herbicide and method of preparation of novel chloroacetylaminopyrimidines | |
GB2155012B (en) | Preparation of 2,3-pyridinedicarboxylic acid from 5-halo-8-hydroxyquinoline | |
DE3169435D1 (en) | Preparation of l-aspartic acid n-thiocarboxyanhydride | |
GB2070018B (en) | Synthesis of calcitroic acid and 5,6-transcalcitroic acid | |
JPS5759838A (en) | Manufacture of substituted 4,4'-diaminodiphenylene |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Record of annual fee payments |
Year of fee payment: 12 |